These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 7359629)
1. How to differentiate hyperparathyroid patients among intermittent hypercalcemic urinary stone formers: a combined use of immunoreactive parathyroid hormone and nephrogenous adenosine 3',5'-monophosphate. Kitamura T; Tanaka M; Abe K; Niijima T J Urol; 1980 Mar; 123(3):328-34. PubMed ID: 7359629 [No Abstract] [Full Text] [Related]
2. Nephrogenous cyclic AMP and plasma parathyroid hormone in hypercalcaemia: the influence of renal function. Bill G; Jacquet AF; Burckhardt P Eur J Clin Invest; 1984 Jun; 14(3):227-32. PubMed ID: 6088250 [TBL] [Abstract][Full Text] [Related]
3. [Should the parathyroid function be evaluated in a patient with calcium kidney stones? If so, when and why?]. Gardin JP; Houillier P; Borensztein P; Paillard M Nephrologie; 1991; 12(2):71-7. PubMed ID: 1944759 [TBL] [Abstract][Full Text] [Related]
7. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction. Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269 [TBL] [Abstract][Full Text] [Related]
8. Renal cyclic adenosine monophosphate: an accurate index of parathyroid function. Drezner MK; Neelon FA; Curtis HB; Lebovitz HE Metabolism; 1976 Oct; 25(10):1103-12. PubMed ID: 184364 [TBL] [Abstract][Full Text] [Related]
9. Possibility of elevated parathyroid function in patients with calcium-containing nephrolithiasis as compared with normal controls. Kitamura T; Hirano Y; Ueda D; Niijima T Eur Urol; 1987; 13(1-2):90-9. PubMed ID: 3034619 [TBL] [Abstract][Full Text] [Related]
10. [Primary hyperparathyroidism and nephrolithiasis]. Tiktinskiĭ OL Sov Med; 1978 Oct; (10):99-104. PubMed ID: 362554 [No Abstract] [Full Text] [Related]
11. A spot sample test for the estimation of urinary or nephrogenous cAMP in the evaluation of parathyroid function. Kraiem Z; Glaser B; Rosenzweig A; Sheinfeld M; Ben-Ari J Nephron; 1983; 35(4):264-6. PubMed ID: 6316183 [TBL] [Abstract][Full Text] [Related]
12. Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone. Park-Sigal J; Don BR; Porzig A; Recker R; Griswold V; Sebastian A; Duh QY; Portale AA; Shoback D; Schambelan M J Bone Miner Res; 2013 Mar; 28(3):700-8. PubMed ID: 23074096 [TBL] [Abstract][Full Text] [Related]
13. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. Pak CY; Oata M; Lawrence EC; Snyder W J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891 [TBL] [Abstract][Full Text] [Related]
14. Laboratory tests in the diagnosis of hyperparathyroidism in hypercalcemic patients. Strott CA; Nugent CA Ann Intern Med; 1968 Jan; 68(1):188-202. PubMed ID: 5635317 [No Abstract] [Full Text] [Related]
15. Ionised calcium levels in "normocalcaemic" hyperparathyroidism. Muldowney FP; Freaney R; Spillane EA; O'Donohoe P Ir J Med Sci; 1973 Sep; 142(5):223-9. PubMed ID: 4755426 [No Abstract] [Full Text] [Related]
16. Response to an oral calcium load in nephrolithiasis patients with fluctuating parathyroid hormone and ionized calcium levels. Gomes SA; Lage A; Lazaretti-Castro M; Vieira JG; Heilberg IP Braz J Med Biol Res; 2004 Sep; 37(9):1379-88. PubMed ID: 15334204 [TBL] [Abstract][Full Text] [Related]